Buffalo Grove, IL, United States of America

Albert Khilevich

This inventor holds 2 USPTO granted patents. Top assignees: Abbott Laboratories Corporation, Pharmacia Corporation. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Albert Khilevich. Retrieved from https://idiyas.com/inventor/albert-khilevich-frdohofy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 11.1

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Albert Khilevich

Introduction: Albert Khilevich is an accomplished inventor based in Buffalo Grove, Illinois, known for his contributions to the field of pharmaceutical compounds. With two patents to his name, Khilevich has made significant strides in the development of novel therapeutic agents.

Latest Patents: Khilevich's latest inventions include groundbreaking patents for "Gem-substituted αvβ3 antagonists" and "Imidazoles and related compounds as α1A agonists." These innovations hold promise for advancements in medical treatments, particularly in addressing various health conditions.

Career Highlights: Throughout his career, Khilevich has been associated with prominent companies in the pharmaceutical industry. He gained valuable experience working at Pharmacia Corporation and Abbott Laboratories Corporation. His work at these institutions highlights his commitment to research and innovation in drug development.

Collaborations: In addition to his work at major corporations, Khilevich has collaborated with notable coworkers in the field, including Ish K Khanna and Yi Yu. These partnerships have played a crucial role in advancing his research endeavors and strengthening his contributions to the scientific community.

Conclusion: Albert Khilevich continues to be a significant figure in the world of pharmaceutical innovations. His patents and collaborative efforts underline his dedication to advancing medical science and improving therapeutic outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…